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Equisetum giganteum L., commonly called ‘‘giant horsetail’’, is an endemic species of Latin America.
Its aerial parts have been widely used in ethnomedicine as a diuretic and in herbal medicine and food
supplements as a raw material. The phenolic composition of E. giganteum stems was studied by liquid
chromatography coupled to diode array detection (LC–DAD) and liquid chromatography coupled to
electrospray ionization-tandemmass spectrometry (LC–ESI-MS/MS), which identiﬁed caffeic acid derivatives,
ﬂavonoids and styrylpyrones. The most abundant glycosilated ﬂavonoids in this sample were kaempferol
derivatives. Other rare phenolic components, namely, quercetin-3-O-(caffeoyl)-glucoside and 3-hydroxy-
hispidin-3,40-di-O-glucoside, were reported for ﬁrst time in the Equisetum genus. An LC-UV method for the
simultaneous quantiﬁcation of ﬂavonoid aglycones in E. giganteum obtained after hydrolysis was developed
and validated. The method exhibited excellent linearity for all analytes, with regression coefﬁcients above
0.998, LODZ0.043 mg mL1, LOQZ0.158 mgmL1 and recovery rates of 96.89–103.33% and 98.22–102.49%
for quercetin and kaempferol, respectively. The relative standard deviation for the intra- and inter-day
precision wasr3.75%. The hydrolysis process was optimized by central composite rotational design and
response surface analysis. The second-order response models for the aglycones contents were as follows:
quercetin (mg g1)¼24.8102þ55.2823HClþ0.776997Time7.23852HCl27.46528E04Time2
 0.229167HClTime; kaempferol (mg g1)¼9.66755þ974.822HClþ11.8059Time130.612
HCl20.0125694Time2 3.22917HClTime, with estimated optimal conditions of 1.18 M HCl and
205min of hydrolysis. The results obtained with these new methods were compared to those from a
spectrophotometric assay used to determine the total ﬂavonoids in the Equisetum arvense monograph
(Horsetail, British Pharmacopoeia 2011). For all four species analyzed (E. giganteum, E. arvense, E. hyemale and
E. bogotense), the calculated aglycone content was higher using the optimized hydrolysis conditions.
Additionally, the LC method was more appropriate and speciﬁc for quantitative analysis.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Equisetum giganteum L. (Equisetaceae, subgenus Hippochaete),
commonly known as ‘‘cavalinha’’, ‘‘cola de caballo’’, ‘‘horsetail’’ or
‘‘giant horsetail’’, is a lower vascular plant widespread in Southern
and Central America. This species is used in traditional medicine in
Mexico, Guatemala, Venezuela, Argentina and other countries, mainly
for its diuretic, astringent, hemostatic and remineralizing properties.
It is also used to treat liver and urinary disorders, among other
applications [1–5]. In southern Brazil and Argentina, E. giganteum
infusions are often used as a diuretic and for weight loss. The in vivoll rights reserved.
ax: þ55 51 3011 5050.
r (L.N. Francescato).diuretic activity of the extracts of this species has been veriﬁed [3,4],
and no oral acute toxicity was observed in mice [1].
In Brazil and Argentina, the drug is widely used and commercia-
lized as a raw material for herbal medicines and as a food supple-
ment. In these and other Latin American countries, E. giganteum is
commonly used as a substitute for E. arvense (Horsetail herb, Equiseti
herba), a European species with conﬁrmed diuretic activity and a long
history of clinical use as well as a well-known phytochemical proﬁle
[6,7]. Moreover, several pharmacopoeias include monographs of
E. arvense. In the case of E. giganteum, the only known data about
its chemical composition have been obtained from metal and silica
content analyses, ash determination [5] and oleoresin analysis
employing gas chromatography–mass spectrometry [8]. No data on
its phytochemical composition have been published.
Considering the wide use of these plants as a raw material in
herbal medicine, it is necessary to develop reliable quality control
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pose, the pharmacognostic parameters for E. giganteum have been
examined [9]. Thus, the aim of this study was to determine, for
the ﬁrst time, the phenolic proﬁle of E. giganteum using liquid
chromatography coupled with tandem mass spectrometry (LC–
MS/MS) and to develop and validate a liquid chromatography
coupled with ultraviolet detection (LC–UV) method for the
quantitation of ﬂavonoid aglycones, including a previous statis-
tical optimization of the acid hydrolysis of their glycosides. Four
Equisetum species were evaluated: E. giganteum, E. arvense,
E. hyemale and E. bogotense. The results obtained using this
method were compared to those obtained using the hydrolysis
and spectrophotometric method described for E. arvense in the
British Pharmacopoeia 2011 [10].2. Materials and methods
2.1. Plant material
The aerial sterile stems of Equisetum giganteum L. were
collected in Santo Antoˆnio da Patrulha (RS, Brazil) in May 2011
(sample 1) and October 2009 (sample 2) [9]. E. hyemale L. was
collected in August 2009 in Curitiba (PR, Brazil). E. bogotense
H.B.K. was collected in August 2008 in Bariloche (Rı´o Negro,
Argentina). A commercial sample of E. arvense L. was purchased in
Spain, having been bottled in July 2008. All samples were
identiﬁed botanically. The material was dried and ground to a
particle size o0.355 mm. Loss on drying was determined at
105 1C for 4 h.
2.2. Chemicals and reagents
Distilled water and analytical-grade reagents were employed
in the spectrophotometric and hydrolysis experiments: 37%
hydrochloric acid from Quimex (SP, Brazil) and methanol, ethyl
acetate and anhydrous sodium sulfate from Synth (SP, Brazil).
Ethanol (95%, Synth, SP, Brazil), ultra-pure water (Millipore, MA,
USA) and HPLC-grade acetonitrile, methanol and formic acid 96%
(Tedia, OH, USA) were used for chromatographic analysis.
Analytical-grade standards of quercetin (Janssen Chimica,
Belgium), kaempferol (Chromadex, CA, USA) and astragalin (97%,
Sigma-Aldrich, MO, USA) were used as reference compounds.
2.3. LC–MS/MS and LC–DAD qualitative analysis
2.3.1. Sample preparation
The powdered material of E. giganteum (0.4 g, sample 1) was
extracted with 2 mL of 50% aqueous ethanol (v/v) for 30 min by
sonication, centrifuged (1500g) and ﬁltered (0.22 mm PVDF, Milli-
pore, MA, USA). The obtained extract was diluted with ultrapure
water (1:5) prior to use in LC–DAD and LC–MS analysis.
2.3.2. Instruments
LC-MS/MS analysis was performed on an Agilent 1200 series HPLC
(Palo Alto, CA, USA) equipped with a G1312B SL binary pump, a
G1367D high-performance auto-sampler (HiP ALS SLþ) and a
G1316B SL thermostated column compartment. The mass spectro-
meter was an Agilent model G6460A triple quadrupole instrument
equipped with an electrospray ionization source. Instrument control,
data acquisition and processing were performed using MassHunter
workstation software (Qualitative Analysis, version B.03.01, Agilent).
A Phenomenex Luna C18(2) column (2504.6 mm2 i.d., 5 mm
particle; Torrance, CA, USA) was used.
A Waters Alliance 2690 Chromatograph Separations Module
equipped with a multiple-UV-wavelength photo-diode arraydetector (Model 996, Waters, Milford, MA, USA) was used for
liquid chromatography coupled to diode array detection
(LC–DAD) analysis. UV spectra were recorded in a range of
210–400 nm and monitored at 254 nm. Instrument control
and data acquisition were performed using Waters Empower
Software 2002.
2.3.3. LC–MS/MS and LC–DAD conditions and parameters
Samples were eluted with a gradient of previously degassed
0.3% (v/v) formic acid in water (eluent A, pH 2.2) and acetonitrile
(eluent B). The gradient proﬁle was 9–15% B (0–21 min), 15–22%
B (21–45 min), 22–35% B (45–60 min), 35–90% B (60–65 min) and
90% B (65–70 min). Separation was carried out at a ﬂow rate of
0.9 mL min1 at 30 1C and the injection volume was 10 mL.
Mass spectra of the column eluate were recorded in the range
m/z 100–1000. The instrument was operated with a capillary
voltage of 3500 V and a nozzle voltage of 500 V. Nitrogen was
used as the nebulizer gas at 45 psi, a carrier gas of 6 L min1 at
350 1C and a sheath gas of 11 L min1 at 350 1C. MS data were
acquired in negative and positive ionization modes for the
accurate determination of the m/z of the parent ions. MS/MS data
were acquired in negative ionization mode to obtain the m/z of
the fragment ion. For structural interpretation, the MS/MS
fragment ions were acquired using different collision-induced
decomposition energies (CID) of 10, 20, 30, 50 and 70 V with a
fragmentor voltage of 135 V. The classical nomenclature proposed
by Domon and Costello [11] in the MS/MS spectra of glycosides
was adopted to name the fragment ions.
For LC–DAD analysis, the same chromatographic parameters
described for LC-MS/MS analysis were employed, with the excep-
tion of an injection volume of 15 mL.
2.4. LC–UV quantitative analysis
2.4.1. Preparation of standard and sample solutions for LC–UV
method validation
Quercetin and kaempferol standards were dissolved in metha-
nol and diluted to give seven concentrations in the range of
0.175–43.7 mg mL1 and 0.222–55.6 mg mL1, respectively.
E. giganteum (sample 2) was hydrolyzed in 1.8 M HCl for
120 min, extracted and dissolved in methanol according the
conditions described below (2.4.5).
2.4.2. Instruments
For the quantitative determination, LC–UV analysis, a Waters
Alliance 2695 Chromatograph Separations Module equipped with
a UV/VIS detector (Model 2487, Waters) was used. The Luna
C18(2) column (4.6250 mm2, 5 mm, Phenomenex, CA, USA)
was protected by a Bondapak C18 guard-column (18 mm2,
37–55 mm, Waters, MA, USA). To evaluate the speciﬁcity, a
multiple-UV-wavelength photo-diode array detector (Model
996, Waters) was also used. Empower Software 2002 (Waters)
was used for instrument control, data acquisition and processing
of the chromatographic information.
2.4.3. LC–UV conditions and parameters
The separation of aglycones was achieved using a linear
gradient of water (A) and methanol (B), both acidiﬁed with 0.3%
formic acid (v/v). The gradient proﬁle was 47–60% B (0–15 min),
60% B (15–23 min), 60–100% B (23–24 min) and 100% B (24–
27 min). At the end of each analysis, the column was stabilized for
10 min under the initial conditions. A volume of 10 mL of the
sample was eluted with a ﬂow rate of 0.9 mL min1 and detected
at 370 nm; the column temperature was 2272 1C.
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The method linearity, precision (repeatability and intermedi-
ary precision), accuracy (recovery), speciﬁcity, detection and
quantitation limits were evaluated according to the ICH guide-
lines [12].
Linearity: Linearity was determined by the calibration curves
obtained from the LC analysis of the standard solutions of
quercetin and kaempferol. The linearity analysis, over a 3 day
period, was estimated by regression using the least squares method.
Seven concentrations of quercetin and kaempferol in the range of
0.175–43.7 mg mL1 and 0.222–55.6 mg mL1, respectively, were
employed.
Accuracy: The accuracy was determined by recovery analysis.
Measured amounts of quercetin (0.091, 0.272 and 0.453 mg mL1)
and kaempferol (1.08, 3.24 and 5.4 mg mL1) were added to the
hydrolyzed extract solution to create solutions with 80, 100 and
120% of the theoretical concentration. Each sample was injected
three times and the amount recovered was calculated. Controls
from all samples were prepared and analyzed.
Precision: To evaluate the repeatability and intermediate pre-
cision (intra- and inter-day precision), ﬁve concentration levels
(50 to 150%) of the hydrolyzed extract were prepared and injected
in triplicate on three different days. A new sample solution was
prepared each day. The results were expressed as relative stan-
dard deviation (RSD, %).
Speciﬁcity: The speciﬁcity was determined by peak purity tests
using a diode array detector after adding a small amount of the
standard substances to the sample.
Limit of detection and limit of quantitation: The limit of detec-
tion (LOD) and limit of quantitation (LOQ) were deﬁned as signal-
to-noise ratios of 3.3:1 and 10:1, respectively. The standard
solutions of quercetin and kaempferol for LOD and LOQ were
prepared by sequential dilution.
Robustness: A Plackett–Burman (P–B) design was employed to
test the robustness of the method. Four factors were tested:
column (two batch and age), formic acid concentration (0.28,
0.3 and 0.32%, v/v), percentage of MeOH in the initial mobile
phase composition (46, 47 and 48%) and ﬂow rate (0.85, 0.9 and
0.95 mL min1). Eight experiments were evaluated with 3 factors
assigned to dummy factors, in triplicate and randomly. Three
responses were evaluated: the area, retention time and width of
the quercetin and kaempferol peaks. The analyses of the results
and statistical interpretations of the effects were derived from the
literature [13]. The standard error was obtained from the dummy
effects. A response at the 5% level (a¼0.05) was considered
signiﬁcant.2.4.5. Hydrolysis and extraction
Powdered E. giganteum (0.4 g of sample 2) was reﬂuxed in a
water bath at 9071 1C with 40 mL of various ﬁnal molar
concentrations of HCl in 50% aqueous methanol for different
time-periods (see next subsection). The liquid was ﬁltered
through cotton, and the residue was extracted twice with metha-
nol (10 mL) under reﬂux (9071 1C) for 10 min. The extracts were
combined, and the methanol was removed at reduced pressure
(30–35 1C). Ten milliliters of water were added to the residue and
extracted once with 20 mL and then three times with 10 mL of
ethyl acetate. The combined ethyl acetate extracts were washed
twice with 50 mL of water and then ﬁltered over 10 g of
anhydrous sodium sulfate. The resulting solution was dried at
reduced pressure (o40 1C). The residue was resuspended in 5 mL
of methanol, 5-fold diluted in the same solvent and ﬁltered
through a 0.45 mm PVDF ﬁlter (Millipore, MA, USA) prior to LC
analysis.2.4.6. Experimental design and optimization of hydrolysis
by response surface methodology (RSM)
The acid hydrolysis of the E. giganteum raw material was
optimized using central composite rotational design (CCRD) and
response surface analysis [14,15] to maximize its efﬁciency while
avoiding the degradation of the ﬂavonoid aglycones.
According to results obtained in preliminary research on the
efﬁciency of the acid hydrolysis of ﬂavonoid glycosides, the most
relevant variables were identiﬁed as the HCl concentration and
hydrolysis time. CCRD was developed using Minitabs 15.0 Statistical
Software (Minitab Inc., USA). Twelve experiments were performed in
two orthogonal blocks with 2 center points per block. The values of
the variables were coded as 71 for the factorial points, 0 for the
center points and 71.4142 for the axial points. The ranges of the
variables evaluated were 1.02 to 4.98M for HCl concentration and
35.1 to 204.9 min for hydrolysis time (see Table 4).
The experimental data were ﬁtted in the second-order poly-
nomial model encoded in
Y ¼ b0þb1X1þb2X2þb11X21þb22X22þb12X1X2 ð1Þ
where Y is the response variable to be modeled; b0, b1, b2, b11, b22
and b12 are the regression coefﬁcients; X1 is the molar concentra-
tion of HCl; and X2 is the hydrolysis time.
The suitability of the model for each extracted ﬂavonoid aglycone
was veriﬁed by analysis of variance (ANOVA). The optimum HCl
concentration and hydrolysis time were obtained from the model by
inspecting the response surface contour plots and using the Minitabs
optimizer. The determination of ﬂavonoid aglycones was carried out
by LC–UV after hydrolysis at the optimum conditions, and the result
was compared to the predicted value.2.5. Statistical analysis
Analyses were performed in triplicate. The individual data were
grouped after each experiment. The mean with the respective
deviation was used as a measurement of the central tendency and
dispersion (RSD, %). Microsoft Excel software (Microsoft, USA) and
Minitabs 15.0 Statistical Software (Minitab Inc., USA) were employed
for ANOVA.3. Results and discussion
3.1. Qualitative analysis
The LC-DAD and LC–ESI-MS proﬁles of E. giganteum hydro-
ethanolic extract are shown in Fig. 1, and the chromatographic,
UV, MS and MS/MS data can be observed in Table 1.
The molecular mass of the compounds was obtained from
their positive and negative ion electrospray mass spectra
(ESI-MS), which described the corresponding protonated and
deprotonated pseudomolecular ions as well as the sodium and
potassium adduct ions (Table 1). In some cases, sodium formate
adduct ions ([Mþ68] and [Mþ136]), formed due to the
presence of formic acid in mobile phase A (data not shown) were
observed in the negative ion mode ESI-MS. After the pseudomo-
lecular ion identiﬁcation, it was subjected to various CID energies
(10, 20, 30, 50 and 70 V) in negative ion mode ESI-MS/MS to
detect the site of substitution in the aglycones, thereby providing
ﬁrm evidence for the proposed compound structure.
Thus, the structure of 12 compounds present in hydroethano-
lic extract of E. giganteum were fully or partially characterized
using the combined interpretation of the retention time, UV
spectra and fragmentation patterns of the compounds obtained
by LC–DAD and LC–ESI-MS/MS. These data were compared with
Fig. 1. LC–DAD chromatogram at 254 nm (a) and LC–ESI-MS (negative ion mode) total ion current (TIC) chromatogram (b) of the hydroethanolic extract of E. giganteum.
The peaks are labeled according to the compounds listed in Table 1.
L.N. Francescato et al. / Talanta 105 (2013) 192–203 195literature data, mainly those for the phenolics present in other
Equisetum species [7,16–18].3.1.1. Characterization of ﬂavonoid derivatives
In combination with the application of different CID energies
in negative ion mode ESI-MS/MS, the UV spectral data were used
to characterize the site of substitution in the ﬂavonoid aglycone.
Band II is important for the identiﬁcation of hydroxyl or methoxyl
substituents in the ring B, and hypsochromic shifts in Band I and/
or II can indicate the methylation or glycosidation of the hydroxyl
groups of ﬂavonols [19]. Shoulders in the UV spectra can also
indicate substitution in aglycones: kaempferol (266, 294sh,
349 nm for 3-glycosides and 266, 318sh, 349 nm for 3,7-diglyco-
sides) and quercetin (255, 266sh, 355 nm for 3-glycosides and
255, 266sh, 294sh, 354 nm for 3,7-glycosides) [20].
Four peaks (compounds 2, 6, 10 and 12) had UV spectra
compatible with kaempferol glycosides. The UV spectra of com-
pounds 2 and 6 showed a Band I maximum at 346.5 nm and a
shoulder at 318 nm, indicating 3,7-O substitution. In contrast, the UV
of the compounds 10 and 12 showed a Band I maximum at 344.1 nm
and a shoulder at 290 nm, indicating a 3-O substitution [19,20].
The Y0
7 [M-H-162] at m/z 609 (compound 2, [M-H] of m/z
771.1 amu) andm/z 447 (compound 6, [M-H] ofm/z 609 amu) were
the base peak at 20 and 30 V of CID energy, indicating the loss of a
glucose residue at the 7-O position, which is preferential [20]. For
compound 2 (at 30 V), the ion 0,2X0
 [M-H-120] at m/z 651.2, with
low intensity (0.6%), and the ion Y70Z
3
1 [M-H-342]
 at m/z 428.7
(1.6%) (Table 1) indicated the 1-2 interglucosidic linkage and
breakdown of a sugar moiety with the loss of one glucose residue,
respectively, which are characteristic of the ﬂavonoid 3-O-sophoro-
side. The ionm/z 445.8 indicated the ﬂavonoid 3- or 7-O-glucosyl, and
the ion with m/z 284.8 indicated the aglycone, kaempferol [21]. For
compound 6, the characteristic ion Z1
 [M-H-180] , indicating 1-2
interglycosidic linkage, was not detected. The ions 0,2X0
 [M-H-120]
at m/z 488.9 and [M-H-282] at m/z 327 indicated breakdown with
partial loss of a hexose residue. The Y3,70 [M-H-324]
 ion atm/z 284
indicated kaempferol [21]. The homolytic cleavage of the 3,7-O-
glycosidic bond in compounds 2 (at 70 V) and 6 (at 50 V) produced
the radical aglycone ions [Y0-2H]
 m/z 283 (base peak) and
[Y0-H]
 m/z 284 as well as the aglycone [Y0] ion m/z 284.9/ 285,
indicating a di-O-glycoside [22,23]. The ionsm/z 255/254.8 and 226.8/
226.6, for compound 2 and 6, respectively, conﬁrmed kaempferol
[24], whereas the ion m/z 151.2/150.6 indicated the presence of a7-O-glucoside [25]. Thus, compound 2 was identiﬁed as kaempferol-
3-O-sophoroside-7-O-glucoside and compound 6 as kaempferol-3,7-
di-O-glucoside. The inﬂuence of increasing fragmentation energy
(CID) on the fragmentation pattern of compound 2 can be visualized
in Table 1 and Fig. 2.
For compound 10 ([M-H] of m/z 609 amu), the base peak Y0
3
[M-H-325] at 30 V indicated the loss of a diglucose residue and
the kaempferol deprotoned aglycone at m/z 284. The character-
istic ion Z1
 [M-H-180] at m/z 428.9 indicated the 1-2 inter-
glycosidic linkage of the ﬂavonoid sophoroside. For compound 12
([M-H] of m/z 447 amu), the Y0
3 [M-H-163] (base peak at
30 V) indicated the loss of a glucose residue and kaempferol at
m/z 283.9. The ion 0,2X0
 [M-H-120] , indicating the loss of a
sugar residue, was only detected at 20 V [21]. For compounds 10
and 12, the homolytic cleavage of the 3-O-glycosidic bond
produced more intense radical aglycone [Y0-H]
 ions m/z 284
and 283.9 than the aglycone [Y0]
 ions m/z 284.9 and 284.8,
respectively, conﬁrming the glycosylation site at 3-O position
[22,23]. The ions m/z 255 and 227, formed in MS/MS at 50 and
70 V for compound 10 and 30 and 50 V for compound 12,
respectively, are characteristic of kaempferol [24]. The ion m/z
151, characteristic of kaempferol-7-O-glucoside, was not detected
for either compound [25]. Compound 10 was identiﬁed as
kaempferol-3-O-sophoroside, and compound 12 was unambigu-
ously identiﬁed as astragalin (kaempferol-3-O-glucoside) based
on a comparison of the retention times and MS and MS/MS
spectra with those of a reference compound.
Compound 1 and 4 exhibited UV spectra characteristic of a
quercetin derivative. The Band I maximum at 351.3 and 348.9 nm
and the shoulder at 294 nm of compound 1 and 4 indicated a 3,7-O
substitution. The characteristic ions Z1
 and 0,2X0
 of 1-2 intergly-
cosidic linkages were not detected [21] for either ﬂavonoid. The
presence of ions at m/z 300.5 and 300.8 at 30 V, in addition to the
fragment ions at m/z 271 and 270.9 at 70 V for compound 1 and 4,
respectively, indicated the aglycone quercetin [24].
The fragmentation pattern of compound 1 ([M-H] of m/z
787 amu) indicated the presence of 3 hexoses linked to
the aglycone by two or three O-glycosidic linkages. At 30 V, the
[M-H] ion m/z 787 was the base peak, followed by the
[M-H-162] ion m/z 625 (34.2% R.A.), [M-H-325] ion m/z 462
(30.7%) and [M-H-487] ion m/z 300.5 (3.7%), making it difﬁcult
to infer the location of the substitution from the relative abun-
dances. At 50 V, the base peak was the ionm/z 462, indicating that
there is a hexose residue possibly linked at 3-O position (the
Table 1
Retention time (Rt), UV absorptions (lmax), negative and positive ion mode ESI-MS and negative ion mode ESI–MS/MS data of phenolic compounds presents in














MS/MS (R.A. %) [MþH]þ [MþNa]þ
[MþK]þ




787 10 787.1 (100), 625.1 (0.7) 789.1 811.3 Quercetin-tri-O-
hexoside20 787.1 (100), 624.7 (5.9) 827.2
30 787 (100), 625 (34.2), 462 (30.7), 300.5 (3.7), 242.8 (9)
50 462 (100), 300 (31), 298.8 (87.8)
70 299.7 (2.7), 298.9 (100), 271 (16.4), 150.6 (2.1)
2 10.1 (0.32) 265.2,
318sh,
346.5
771.1 10 771.1 (100), 609.1 (59.3), 607.9 (0.4), 284 (0.4) 773.3 795.2 Kaempferol-3-O-
sophoroside-7-O-
glucoside
20 771.1 (13.6), 609.2 (100), 284.8 (0.2), 284.1 (0.4) 811.2
30 770.7 (0.4), 651.2 (0.6), 609 (100), 445.8 (3.1), 428.7 (1.6),
284.8 (2.5), 284 (3.6), 282.3 (0.4), 178.6 (0.3)
50 609.1 (7.9), 446 (19.4), 428.9 (5.8), 325.9 (2.2), 285 (42.5),
284 (100), 282.9 (43.1), 254.8 (5.3), 179.1 (1.8), 178.6 (1.4),
151 (2.4)
70 309.1 (0.6), 284.9 (29.5), 284 (49.9), 283 (100), 256.9 (1.7),
255.9 (1.7), 255 (61.2), 226.8 (12.9), 181.7 (0.8), 151.2 (1.9)
3 12.5 (0.30) 253.4,
268sh,
361.8c
585.1 10 585.1 (100), 422.9 (4.2) 587.2 609.2 3-Hydroxyhispidin-3,
40-di-O-glucoside20 585.0 (100), 423.1 (21.2), 422 (2.8), 259.8 (2.5), 259.1 (1.9),
241 (2), 217.2 (2.7), 215.9 (2.2), 202.8 (2.4)
625.2
30 585 (63.6), 423.1 (100), 422.1 (26.7), 379.1 (14.1), 259.9
(90.3), 259 (96.4), 257.8 (6.5), 230.8 (28), 217 (41.7), 216
(44.8), 214.9 (6.3), 202.9 (52.3), 159 (6.9)
50 259.5 (10.1), 259 (8.4), 216.9 (11.5), 215.9 (10.6), 202.9
(100), 188 (7.6), 186.7 (19), 174.3 (7.8), 171 (5.1), 159 (60.2),
142.4 (6.4)
70 203 (19.9), 186.9 (6.9), 175.3 (3.7), 172.8 (3.2), 170.8 (8.9),
159 (100)




625.1 10 625 (100), 462.9 (6.1) 627.3 649.2 Quercetin-3,7-di-O-
glucoside20 625.1 (100), 462.8 (31.3), 461.8 (4.6) 665.1
30 624.5 (6.9), 463 (31.5), 462 (100), 300.8 (29.3), 299 (11.7)
50 301 (10.3), 299.9 (3.9), 298.8 (100), 270.9 (3.2)
70 300.8 (10.7), 298.6 (48.6), 270.9 (100), 243.1 (4.1), 242.2
(5.3)
5 16.5 (0.73) 246.2,
295sh,
327.3
625.1 10 624.9 (100), 462.9 (42.4) 627.1 649.2 Quercetin-3-O-
(caffeoyl)-glucoside20 624.8 (10.3), 463.1 (100), 462.4 (42.1), 341.5 (13.5) 665.0
30 463.1 (100)
50 300.8 (46.8), 300.1 (72.5), 270.9 (100), 255.1 (99), 227.1
(30.4)
70 270.6 (93.3), 254.7 (84.1), 242.6 (100)
6 18.2 (0.85) 265.2,
318sh,
346.5




20 609.1 (65.2), 489.1 (6.8), 447 (100), 445.8 (9.4), 285.1 (23.4),
282.8 (1.5)
30 609.2 (1.6), 488.9 (2.3), 460.1 (1.1), 447 (100), 446 (77). 327 (4),
285 (85.8), 283.9 (3.6), 283 (24), 269.2 (1), 255.1 (2), 151 (0.9)
50 446.7 (0.7), 445.9 (0.5), 297.2 (0.6), 285 (60.5), 284 (11), 283
(100), 254.8 (13.8), 226.6 (2.2), 150.6 (1.1)
70 284.9 (18.5), 282.9 (44.3), 254.9 (100), 227.1 (10.2), 183 (5.3)
7 22.2 (0.64) 267.6,
353.5
625 10 625.1 (100) 627.2 649.2 Flavonol-di-O-
hexoside20 625.2 (58.1), 624.6 (100), 463.2 (8.1) 665.2
30 625.1 (34.5), 624.6 (35), 463 (100), 462.2 (19.4), 461.5 (7), 299.9
(5.6)
50 300.4 (22.5), 299.9 (18.3), 299 (64.2), 271.1 (100), 254.8 (25.6),
201.1 (10.4)
70 270.7 (84.2), 255.2 (100), 254.6 (95.2), 227 (21.1)
8 23 (0.73) 253.4,
272sh,
371.4
423 10 423 (100), 379.1 (1.8), 378.4 (0.8), 286.9 (1.2), 261 (8.6), 260
(1.5), 217 (1.1), 215.9 (0.8)
425.1 447.1 Equisetumpyrone
463.1
20 423 (100), 261.1 (62.7), 260.1 (49.2), 216.9 (32.3), 216 (25.5),
202.9 (49.5), 198.8 (8), 189.2 (8), 188.1 (17), 172.9 (7.6), 161
(6.9), 159 (4.9), 135 (8.8), 127.1 (5.6)
30 260.9 (14.4),259.7 (12.5), 216.9 (24.7), 216.1 (6.1), 215.5
(10.7), 202.8 (100), 197.3 (6.7), 188 (18.7), 187 (13.1), 174.1
(6.1), 172.8 (11.2), 172.1 (6.7), 161.1 (7.3), 159 (22.4), 135.1
(14)
50 202.8 (100), 186.9 (34.4), 175 (7.3), 171.1 (4.4), 159 (41), 158
(4.9), 144 (7.8), 135 (15.5), 108.9 (7.3)
70 203 (36.6), 186.7 (18.6), 160.8 (11.8), 159.8 (5.5), 159 (100),
135.1 (11.6), 134.3 (12.1), 132.6 (7.3)
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MS/MS (R.A. %) [MþH]þ [MþNa]þ
[MþK]þ
9 24.9 (0.60) 244,
298sh,
327.3
295 10 201 (52.4), 200.4 (11.8), 179.1 (29.1), 134.9 (7.5), 132.7 (100),
114.6 (8.8)
 319.1 Caffeic acid derivative
335
20 200.8 (68.9), 178.8 (54.8), 135.2 (100), 134.2 (84.8), 133.2
(83.4), 115 (98.3)
30 134.9 (80.2), 133.7 (18.6), 115.2 (100)
50 135 (83.5), 133.6 (100)
10 30.6 (0.52) 265.2,
290sh,
344.1
609 10 609.1 (100), 283.4 (0.4) 611.2 633.2 Kaempferol-3-O-
sophoroside20 609.1 (100), 428.9 (2.1), 285 (5.4), 284.1 (7) 649.2
30 609.1 (14.2), 446.8 (1.3), 428.9 (5.3), 284.9 (15.3), 284 (100),
256.9 (1.6), 178.8 (1.3), 126.8 (1.5)
50 285 (8.7), 284 (100), 255 (77.5), 228.9 (3.9), 226.9 (51.6)
70 283.4 (4.6), 255 (100), 227 (60.3), 210.8 (5.1)
11 37.6 (0.53) 241.5,
298sh,
327.3
309 10 192.9 (100), 177.6 (7.1), 134.2 (22.5), 133.5 (9.3), 115.1 (10.7)  333.1 Ferulic acid derivative
349.220 193.1 (13.1), 192.5 (14.1), 134 (100), 117.1 (9.3)
30 134.2 (100)
12 42.2 (0.54) 265.2,
290sh,
344.1
447 10 447 (100), 284.6 (3.6) 449 471.1 Kaempferol-3-O-
glucoside48720 447.1 (100), 326.6 (11.1), 285.2 (38.1), 284.7 (34.9), 283.9
(61.8), 255.2 (7.9), 226.7 (19), 174.6 (16.8)
30 447 (10.1), 284.8 (6.2), 283.9 (100), 254.8 (52.1), 227 (14.2),
174.7 (13)
50 256.1 (5.1), 255 (100), 254.5 (37.5), 227 (69.3)
70 226.8 (100), 211.2 (8), 183.1 (20.7), 181.8 (11.6)
a Percent relative standard deviation of the triplicate measurements.
b Shoulders obtained visually.
c Other compound coeluting in the same peak. UV spectra maxima tentatively selected for the compound of interest.
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O-glycosidic bond produced (at 70 V) radical aglycone ions [Y0-
2H] m/z 298.9 (high abundance) and [Y0-H] m/z 299.7 (low
abundance), but the aglycone ion [Y0]
 m/z 301 was not observed.
The ion [Y0-2H]
 indicated the presence of a di-O-glycoside [22],
but no reference to the absence of an aglycone ion was found in
literature. Attributing this peak to the tri-O-glycosidic linkage,
compound 1 was identiﬁed as quercetin-tri-O-hexoside.
In compound 4 ([M-H] of m/z 625.1 amu), the ion Y70 [M-H-
162] (base peak) atm/z 462 appears at 30 V, indicating the loss of a
hexose residue in the 7-O position, which is preferential. The
Y3,70 [M-H-324]
 ion at m/z 300.8 indicated quercetin [21]. The
homolytic cleavage of the 3,7-O-glycosidic bond produced (at 50 V)
radical aglycone ions [Y0-2H]
 m/z 298.8 (high intensity) and
[Y0-H]
 m/z 299.9 as well as the aglycone [Y0] ion m/z 301,
indicating a di-O-glycoside [22]. Thus, compound 4 was identiﬁed as
quercetin-3,7-O-glucoside.
Compound 5 ([M-H] of m/z 625.1 amu) had a UV spectra
characteristic of a hydroxycinnamic acid, but the fragmentation
pattern indicated an O-substituted ﬂavonol. At 10 V, only the ion
[M-H-162] m/z 462.9 was formed in high intensity after the loss of
the caffeoyl moiety from the pseudomolecular ion [M-H] m/z 624.8.
At 20 V, in addition to the ion m/z 463.1 (100%), the ion [M-H-Caf-
120] m/z 341.5 (13.5%) indicated the breakdown of a sugar moiety.
The homolytic cleavage of the O-substitute bond produced (at 50 V) a
radical aglycone ion [Y0-H]
 m/z 300.1 (72.5%) as well as the
aglycone ion [Y0]
 m/z 300.8 (46.8%), implying a possible 3-O-
substitution [23]. The ions m/z 270.9 and 255.1, formed in MS/MS
at 50 V, are characteristic of quercetin [24]. Based on a comparison of
the MS fragmentation pattern with the literature [26], compound 5
was identiﬁed as quercetin-3-O-(caffeoyl)-glucoside.
Compound 7 ([M-H] of m/z 625 amu) exhibited a UV spectra
typical of a ﬂavonol, and the Band I maximum at 353.5 nmindicated that the compound was 3-O substituted. The ion
[M-H-162] at m/z 463 (base peak), indicated the loss of a
hexose residue. The characteristic ion of a 1-2 interglycosidic
linkage was not detected. The Y3,70 [M-H-324]
 ion at m/z
299.9 indicated the aglycone. The homolytic cleavage of the
O-glycosidic bond produced (at 50 V) radical aglycone ions [Y0-
2H] m/z 299 (high intensity) and [Y0-H] m/z 299.9, indicating
a di-O-glycoside, possibly with 3-O-glycosidic linkage [22,23]. The
ions m/z 271.1 and 254.8, formed in MS/MS at 50 V, indicated the
aglycone quercetin [24], whereas the ion m/z 227 (at 70 V) corre-
sponds to the MS/MS of kaempferol derivatives. Further research is
thus needed to elucidate the structure of this derivative.3.1.2. Characterization of styrylpyrone derivatives
Compounds 8 and 3 exhibited UV spectra characteristic of
styrylpyrone, with maximum in the range of 253–258 nm and
355–373 nm [16].
The results obtained for compound 8 were compared with
literature data [7,16,17]. At low collision energy (10 and 20 V)
in MS/MS, the aglycone ion m/z 261 was detected from the pseu-
domolecular ion [M-H] m/z 423 (base peak), indicating the loss
of a hexose residue (b-glucose) [M-H-162] . Thus, compound 8
was characterized as equisetumpyrone, a styrylpyrone glycoside
(3,4-dihydroxy-6-(30,40-dihydroxy-E-styryl)-2-pyron-3-O-b-D-glu-
copyranoside). This attribution could be conﬁrmed by the pre-
sence of the ions m/z 379.1 and 217 at 10 V, which indicated the
loss of CO2 following the opening of the pyrone ring, and the ions
m/z 159 and 135.1 at 20 V, characteristic of a di-hydroxylated
styryl group [16]. The MS/MS fragmentation pattern of compound
8 at 30 V is presented in Fig. 3.
The results obtained for compound 3 were compared with
literature data [16], and the compound was initially characterized
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that the compound was di-O-substituted because at low collision
energy (10 V) in MS/MS, only the [M-H-162] ion at m/z 422.9,
characteristic of 3-hydroxyhispidin-hexoside, was present, corre-
sponding to the loss of a hexose residue. Furthermore, at 30 V, this
ion was the base peak and the pseudomolecular ion m/z 585 and
aglycone ions at m/z 259.9 and 259 exhibited high relative
abundances (63.5, 89.6 and 96.4% R.A., respectively), which usually
occurs in di-O-substituted compounds [21]. Moreover, the char-
acteristic ion [M-H-180] , typical of a 1-2 interglycosidic linkage
of sophoroside, was not detected with any of the employed
collision energies. Fragments at m/z 379.1, 216, 202.9 and 159,
present in equisetumpyrone spectra, were observed. In the fast
atom bombardment mass spectrometry (FAB-MS) spectra
presented by Beckert [16], in addition to ions m/z 585 and
423, another fragment at m/z 325 was reported, which the author
attributed to sophoroside (not observed in our experiment).
However, that fragment may be due to the cleavage of the pyrone
ring and formation of an ion containing a dihydroxy-styryl-O-
glucoside derivative. Based on these data, compound 3 was
identiﬁed as 3-hydroxyhispidin-3,40-di-O-glucoside (3,4-dihy-
droxy-6-(30,40-dihydroxy-E-styryl)-2-pyron-3,40-O-b-diglucopyra-
noside), although the position of the attachment of the glucose
residue to the dihydroxy-styryl group must to be conﬁrmed by
NMR analysis.Fig. 2. Principal fragmentation pathway and MS/MS [M-H] at CID energies of 10, 23.1.3. Characterization of hydroxycinnamic acid derivatives
Two hydroxycinnamic acid esters were identiﬁed: compounds 9
and 11. These compounds presented UV spectra characteristic of
hydroxycinnamic acid derivatives (with maximum at 324–326 nm
and a shoulder at 296 nm) and fragmentation patterns in accordance
with those reported for caffeic acid ester derivatives [27], with a high
fragmentation tendency even at a low collision energy (10 V). In the
negative ion mode ESI-MS, compound 9, beyond the pseudomolecu-
lar ion m/z 295, an ion indicating a dimeric adduct of the compound
[2M-H] m/z 591 was observed (data not shown).
Compound 9 was identiﬁed as a caffeic acid ester derivative (UV
lmax¼244, 298sh, 327.3 nm; [M-H] ofm/z 295 amu). In the MS/MS
fragmentation at 20 V, the fragment ion [M-116] m/z 178.8 is
formed after the ester breakdown of the pseudomolecular ion m/z
295. This ion, in turn, yielded the ion [M-116-CO2]
 m/z 135.2,
characteristic of caffeic acid. Compound 11 was identiﬁed as a ferulic
acid ester derivative (UV lmax¼241.5, 298sh, 327.3 nm; [M-H] of
m/z 309 amu). In the MS/MS at 10 V, after the ester breakdown with
the loss of a residue [M-H-116] , the fragment ion m/z 192.9
corresponding to ferulic acid (base peak) is produced. This ion then
yielded the ion [M-H-116-CH3]
 at m/z 177.6 after the loss of the
methyl of the methoxy group and the ion [M-H-116-CH3-CO2]
 at
m/z 134.2, indicating the loss of CO2 of the acid group, all of which are
characteristic of a ferulic acid derivative. The fragment with m/z 116
present in both compounds could not be identiﬁed.0, 30, 50 and 70 V for compound 2, kaempferol-3-O-sophoroside-7-O-glucoside.
Fig. 4. Structure of the styrylpyrones and ﬂavonols identiﬁed by LC–MS/MS and LC–DAD in the hydroethanolic extract of E. giganteum.
Fig. 3. MS/MS [M-H] at 30 V for styrylpyrone derivatives: compound 8, equisetumpyrone (a); compound 3, 3-hydroxyhispidin-3,40-di-O-glucoside (b).
L.N. Francescato et al. / Talanta 105 (2013) 192–203 199The pattern of phenolics of E. arvense and other European
Equisetum species is well known: ﬂavonoid O-glycosides (mainly
apigenin, genkwanin, quercetin and kaempferol derivatives),
caffeic acid conjugates (5-O-caffeoylshikimic acid, chlorogenic
acid, dicaffeoyl-meso-tartaric acid and monocaffeoyl-meso-
tartaric acid) and equisetumpyrone [7,28]. Thus, some com-
pounds identiﬁed for the ﬁrst time in E. giganteum in this study
(Fig. 4) have been previously reported for the genus, whereas
other compounds, such as quercetin-3-O-(caffeoyl)-glucoside,
3,4-dihydroxy-6-(30,40-dihydroxy-E-styryl)-2-pyron-3,40-O-b-di-
glucopyranoside, and caffeic and ferulic acid ester derivatives,
are reported for ﬁrst time in the Equisetum genus.
Styrylpyrone glycosides are rare natural products found in a
few species of the Equisetum genus [7,16,17]. Some of these
compounds are found in high levels in the rhizomes, gameto-
phytes and fertile sporophytes of E. arvense and may be involved
in the constitutive defense mechanism against pathogens [16,29].
However, equisetumpyrone was found as one of the majorconstituents, together with other di-O-hexoside styrylpyrone, in
the aerial sterile stems of E. giganteum.
The ﬂavonol glycosides and equisetumpyrone characterized in
E. giganteum and previously described for the Equisetum species
[7,18] can be employed as chemotaxonomic markers. Among the
kaempferol derivatives, the kaempferol-3-O-sophoroside was
reported for all species found in the references evaluated
[7,18,28,30], suggesting its potential use as a marker for the genus.
3.2. Quantitative analysis: ﬂavonoid aglycone determination
As ﬂavonoids are important constituents of Equisetum spp.
and present many recognized medicinal properties, they can be
used as chemical markers for quality control purposes. Chroma-
tographic techniques in combination with UV detection can be
used for the reliable quantitation of individual ﬂavonoid glyco-
sides. However, owing to the complexity of many extracts, the
absence of many commercial analytical standards, the similarity
Table 2
Calibration curves, LOD and LOQ data of ﬂavonoids aglycones determined by LC–UV.
Compound Linearity range (lg mL1) Slope7standard error Intercept7standard error LOD (lg mL1) LOQ (lg mL1) Determination coefﬁcient (R2)
Quercetin 0.175–43.7 43553.4793.6 6580.872293.7 0.047 0.158 0.9997
Kaempferol 0.222–55.6 39563.67197.5 5752.676157.8 0.043 0.205 0.9985
Table 3
Calculated t-values of the factors effects (tcalc) on area, retention time (Rt) and peak
width of quercetin and kaempferol from results of the P–B design.
Factor tcalc
Quercetin peak Kaempferol peak
Area Rt Width Area Rt Width
MeOH % 2.05 9.67a 0.65 0.97 2.00 0.30
Flow rate 6.65a 11.23a 0.29 5.35a 4.38a 0.00
Formic acid % 1.38 0.07 1.44 0.11 1.00 0.00
Column 14.75a 2.33 1.91 7.22a 0.24 2.66a
Dummy 1 0.84 0.87 0.75 0.65 1.38 0.89
Dummy 2 1.35 0.02 1.21 1.19 1.02 0.15
Dummy 3 0.69 1.50 0.98 1.08 0.25 1.48
Critical value t(0.05,3) 2.36
a Signiﬁcant at 5% level.
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reproducibility of retention times on long runs (450 min) and
the possibility of co-eluting compounds, this quantiﬁcation tech-
nique is often difﬁcult to perform. Therefore, quantitative analysis
of the ﬂavonoid aglycones, after the hydrolysis of glycosides, is a
simpler and faster approach because most aglycones are com-
mercially available as reference compounds. Thus, this method is
an attractive alternative appropriate for routine analysis.
Considering the complexity of the plant matrix and the
different ﬂavonoid glycosides (i.e., aglycone moiety, C or O-glyco-
sides bond, substitution position and different types of substitu-
ents), the optimization of the hydrolysis process is necessary to
ensure its efﬁcacy and accuracy.
For the quantitative analysis of the total ﬂavonoid aglycones in
E. arvense, the British Pharmacopoeia 2011 (BP2011) [10] employed a
colorimetric method, which consists of the acid hydrolysis of the
glycosides and their subsequent spectrophotometric determination at
425 nm of a complex formed with AlCl3. Like all methods of this type,
it is non-speciﬁc and most likely inaccurate if applied to the
quantiﬁcation of ﬂavonoid aglycones obtained in E. giganteum because
its ﬂavonoid proﬁle is distinctly different from that of E. arvense [7].
Thus, a LC-UV method to determine each individual aglycone is more
appropriate for this determination, facilitating the interpretation of the
data obtained in hydrolysis optimization procedure.3.2.1. LC–UV method validation
A solvent gradient elution system composed of MeOH:H2O
acidiﬁed with 0.3% formic acid was selected because it afforded
good separation and resolution of the target peaks from their
neighboring unknown compound peaks in the E. giganteum
hydrolyzed extract. The wavelength of 370 nm was selected for
the detection of target analytes because it showed good speciﬁ-
city and sensitivity, particularly for quercetin.
The proposed chromatographic method was validated by evaluat-
ing the LOD, LOQ, linearity, intra- and inter-day precisions, speciﬁcity
and accuracy [12]. The resultant calibration curves, LOD and LOQ of
ﬂavonoid aglycones are presented in Table 2. The calibration curves
were obtained with seven increments of concentrations for standards.
Good linearity is shown for both calibration curves.
Under the established experimental conditions, the recoveries of
quercetin and kaempferol in the three concentrations levels were in
the range of 96.89–103.33% and 98.22–102.49%, respectively. Mea-
surements of these intra- and inter-day precisions for both quercetin
and kaempferol yielded good results in the ranges of 0.32–3.13% RSD
and 1.05–3.75% RSD, respectively (data not shown). The chromato-
graphic peak purity of the analytes in the hydrolyzed extract was
conﬁrmed by analysis with a diode array detector.
The results of the P–B design (Table 3) showed that the
method was more susceptible to wide deliberate variation in
ﬂow rate (above the usual parameters) and the use of a worn-out
column. Care should be taken with these factors whenever the
method is applied. The resolution between the quercetin and
kaempferol peaks of their neighboring unknown compounds was
critical for the results of the robustness test, but even under
extreme hydrolysis conditions, where the intensity of the neigh-
boring peaks increased, this method, under normal conditions,
proved to be speciﬁc for the aglycones of interest.3.2.2. Hydrolysis and characterization of ﬂavonoids
Hydrolysis had been previously evaluated using HCl in acetone
medium (British pharmacopoeic method), but a low yield of
aglycones with a large number of interfering compounds was
obtained after the liquid/liquid extraction with ethyl acetate. The
replacement of acetone by aqueous methanol improved the yield
of aglycones (results not shown). All further experiments were
thus carried out with 50% aqueous methanol (v/v), followed by
the elimination of methanol and liquid/liquid extraction with
ethyl acetate. This procedure allowed the removal of the majority
of the interfering compounds, facilitating the quantitative analy-
sis of ﬂavonoid aglycones.
Applying the developed hydrolysis/extraction method to the
E. giganteum raw material, two ﬂavonol aglycones were observed
in the chromatogram and identiﬁed as quercetin (Rt¼16.1 min,
UV lmax¼253.4, 295sh, 371.4 nm) and kaempferol (Rt¼21.9 min,
UV lmax¼246sh, 262.9, 292sh, 322sh, 366.6 nm) (Fig. 6).3.2.3. Hydrolysis optimization
Quercetin and kaempferol aglycones in the hydrolyzed extract
of E. giganteum (sample 2) were quantiﬁed using the developed
and validated LC method.
The value of independent variables, the design of experiments
through acid hydrolysis and the respective experimental and
predicted yield of quercetin and kaempferol are shown in Table 4.
The results obtained for each aglycone (Table 4) were ana-
lyzed, and the data were ﬁt to a second-order polynomial model
using Eq. (1). The signiﬁcance of each parameter of the model was
evaluated by the t-test. In a ﬁrst analysis, the blocks parameter
presented less than 95% signiﬁcance for kaempferol, but not for
quercetin. Thus, due to the low variability in the levels of
quercetin, we chose to discard the blocks parameter for both
responses. The reduced models were then submitted to an F-test
(ANOVA) to calculate the signiﬁcance of the regression (SOR), lack-of-
ﬁt (LOF) and the coefﬁcient of multiple determination (R2).
After regression analysis, a second-order response model was
obtained as shown in Eqs. (2) and (3) for quercetin and kaemp-
ferol, respectively, and the response surfaces were analyzed and
plotted. The models presented signiﬁcance of the F(SOR) higher
Table 4
Experimental conditions, including factors and levels tested, of the central composite rotational design (CCRD), and experimental and predict quercetin and kaempferol
yield in acid hydrolysis of E. giganteum raw material (sample 2).
Run Block Variables Quercetin yield (lg g1)a Kaempferol yield (lg g1)a
Coded level Natural variables
X1 X2 HCl (M) Time (min) Experimental Predicted Experimental Predicted
1 1 1 1 1.6 60 118 116.7 1585 1568.8
2 1 1 1 4.4 60 112 111.3 1542 1561.5
3 1 1 1 1.6 180 147 144.4 2059 2003.5
4 1 1 1 4.4 180 64 62.1 931 911.2
5 1 0 0 3 120 125 125.5 1797 1812.5
6 1 0 0 3 120 127 125.5 1834 1812.5
7 2 1.4142 0 1.02 120 126 128.1 1646 1689.3
8 2 1.4142 0 4.98 120 65 66.1 919 911.7
9 2 0 1.4142 3 35.1 127 127.7 1808 1798.2
10 2 0 1.4142 3 204.9 110 112.5 1600 1645.8
11 2 0 0 3 120 125 125.5 1800 1812.5
12 2 0 0 3 120 125 125.5 1819 1812.5
X1¼HCl molar concentration; X2¼hydrolysis time.
a Yield in mg g1 of dry weight.
Fig. 5. Response surface (1) and contour plots (2) of HCl molar concentration and hydrolysis time effects on quercetin (a) and kaempferol (b) yield (in mg g1 of dry plant).









The contour and three-dimensional (response surface) plots
describing the effect of HCl concentration and hydrolysis time on
the determination of quercetin and kaempferol in the E. gigan-
teum raw material are presented in Fig. 5. In both plots, the
interaction between the evaluated factors can be observed, with
an improved yield of aglycones from the middle of the runonwards (100 to 204.9 min) and from the lower to the middle
level of HCl molar concentration (1.02 to 3 M), i.e., employing a
lower acid concentration and longer hydrolysis time at 90 1C.
Both higher HCl concentration and extended hydrolysis time
resulted in a decrease in the yield of aglycones, which could be
due to their degradation. On the other hand, lower HCl concen-
tration and hydrolysis times might result in the partial hydrolysis
of ﬂavonoid glycosides, leading to an underestimation of the
ﬂavonoid aglycone content.
From the second-order models, the HCl concentration and
hydrolysis time providing the maximum aglycone yield were
1.1801 M and 204.85 min, which predicted quercetin and kaemp-
ferol yields of 152 and 2069 mg g1 of dry drug, respectively.
A conﬁrmation experiment was conducted for these predicted
optimum conditions (1.18 M HCl and 205 min of hydrolysis,
n¼3). The aglycone yields for E. giganteum (sample 2) were
Table 5
Content of total ﬂavonoids, expressed as isoquercitrin (% w/w dry plant), and content of quercetin and kaempferol aglycones (mg g1 dry plant) in E. giganteum (sample 2),
E. arvense, E. hyemale and E. bogotense.
Assay method Hydrolysis/extraction method Results expressed as E. giganteum E. arvense E. hyemale E. bogotense
Spectrophotometry Pharmacopoeic Isoquercitrin (%, w/w) 0.6670.02a 1.3370.01 0.5170.07 1.1070.04
Developed in this work Isoquercitrin (%, w/w) 1.0570.06 2.4270.26 1.0170.04 1.7470.05
LC–UV Pharmacopoeic Quercetin (mg g1) 0.03870.003 0.57770.066 0.01670.000 0.01370.000
Kaempferol (mg g1) 0.37570.016 0.08870.012 0.40070.051 0.49470.045
Developed in this work Quercetin (mg g1) 0.11670.005 2.31370.176 0.08370.002 0.03370.001
Kaempferol (mg g1) 1.40970.061 0.53370.036 1.38070.055 2.36070.063
a Value expressed as mean7standard deviation of three determinations, in terms of dry plant.
Fig. 6. LC–UV chromatograms at 370 nm of the fraction containing the aglycones
of E. arvense (Ea), E. giganteum (Eg), E. bogotense (Eb) and E. hyemale (Eh), using the
method developed in this work for E. giganteum. UV spectra of quercetin (1),
apigenin (2), kaempferol (3) and an unknown ﬂavonoid (4).
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which were only 3.29% and 7.06% below the predicted values,
revealing the good predictivity capacity of the model.3.3. Aglycone quantiﬁcation in Equisetum spp.
The optimized hydrolysis conditions obtained for the E. giganteum
rawmaterial (1.18MHCl and a hydrolysis time of 205 min at 90 1C in
50% aqueous methanol medium) were employed for the assay of
ﬂavonoid aglycones in several Equisetum species: E. giganteum
(sample 2), E. arvense, E. hyemale and E. bogotense. These samples
were also submitted to the pharmacopoeic hydrolysis method for
Horsetail (0.6 M HCl and a hydrolysis time of 30min under reﬂux in
acetone medium) [10]. The aglycones formed were quantiﬁed using
the spectrophotometric pharmacopoeic method and the LC–UV
method developed and validated in this study. The content of total
ﬂavonoids expressed as isoquercitrin and the content of quercetin
and kaempferol aglycones were thus obtained (Table 5).
The data presented in Table 5 show that the hydrolysis/
extraction method described by the BP2011 [10] yielded lower
values of total ﬂavonoids for all four species, including E. arvense,
compared to those obtained by the application of the hydrolysis/
extraction method developed in this study. The contents of total
ﬂavonoids were between 58 and 98% higher for the four species
compared with levels obtained using the pharmacopoeic method.
In the case of the determination of quercetin and kaempferol
aglycones, the samples obtained with the optimized hydrolysis/
extraction procedure showed a yield of over 153% for all four
species relative to the yield obtained with the extract obtained
using the BP2011 method. For E. arvense, the contents of querce-
tin and kaempferol differed by 301% and 506%, respectively,
between the content calculated in samples obtained with
the optimized hydrolysis/extraction method and the method
described in BP2011. These data reveal the inﬂuence of the
method and hydrolysis conditions in the determination of total
ﬂavonoids and aglycones for the four species analyzed, indicating
that the glycosilated ﬂavonoids present in these samples are not
completely hydrolyzed, which leads to an underestimation of the
total ﬂavonoid content.
The increase in the content of quercetin and kaempferol
observed by LC–UV after the application of optimized hydrolysis
conditions was not proportional to the increase observed using
the spectrophotometric method. This difference demonstrates the
non-speciﬁcity of the spectrophotometric method for aglycone
quantitation. Thus, the LC–UV determination of individual aglycones
was more speciﬁc than the spectrophotometric method, proving to
be more appropriate for the quality control of the Equisetum species
analyzed.
Among these species, E. arvense was the only one with a higher
content of quercetin than kaempferol, as determined by both hyd-
rolysis/extraction methods. Equisetum giganteum, E. hyemale and
E. bogotense exhibited at least 10 times more kaempferol than
quercetin. This difference in the levels of these two aglycones may
be very useful and perhaps decisive in the differentiation of the
analyzed species but also can assist in the identiﬁcation, mainly for
powdered materials in which the botanical identiﬁcation becomes
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objective of ﬁnding a way to differentiate the species chemically
through their aglycone proﬁles was not achieved, with the exception
for E. arvense.
For both assay methods, E. arvense had the highest content of total
ﬂavonoids expressed as isoquercitrin, as well as a higher content of
aglycones (considering only quercetin and kaempferol), followed by
E. bogotense, E. giganteum and E. hyemale. In addition to having the
highest content of aglycones, two other ﬂavonoid aglycones were
detected, although not quantiﬁed, in the hydrolyzed extract of
E. arvense (Fig. 6). These compounds can be observed in the
chromatogram of E. arvense, in which, in addition to quercetin (peak
1, Rt¼15.6 min) and kaempferol (peak 3, Rt¼20.9 min), there are
another two peaks corresponding to apigenin (peak 2, Rt¼22min)
and an unidentiﬁed ﬂavonoid (peak 4, Rt¼17.5 min). In the other
three species, only quercetin and kaempferol aglycones were found
after the hydrolysis of ﬂavonoid glycosides.4. Conclusions
The major phenolic compounds of E. giganteumwere identiﬁed for
the ﬁrst time by LC–DAD and LC–MS/MS. Some of these compounds
were reported for the ﬁrst time in the Equisetum genus.
Glucosylated kaempferol derivatives proved to be the most
abundant ﬂavonoids in E. giganteum, showing potential as quali-
tative and quantitative markers for this species.
Considering that there are no commercial standards available
for most ﬂavonoids in the hydroethanolic extract of E. giganteum,
we developed and validated a reversed phase LC–UV method to
determine the ﬂavonoid aglycones content obtained after an
optimized hydrolysis process. The developed LC–UV method
proved to be simple, sensitive, accurate, linear, precise, reprodu-
cible, speciﬁc and robust.
When applied to the analysis of ﬂavonoid aglycones in
E. giganteum, E. arvense, E. hyemale and E. bogotense raw material,
the developed hydrolysis method showed higher yields than the
method described in BP2011 for E. arvense [10]. These results
indicate that this method is more suitable for the determination
of total ﬂavonoids in Equisetum species. Furthermore, it provided
the ﬁrst description of the chromatographic proﬁle and quantiﬁ-
cation of aglycones in these species.
The results presented in this paper are useful for the differ-
entiation of these Equisetum species and represent a contribution
to the quality control of E. giganteum raw material and deriva-
tives. Additionally, these ﬁndings suggest that this method could
be extended to other species of the genus Equisetum, including
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